Up to date

Appointments

Matthias Schroff, erstwhile CEO of Mologen, has taken over the helm of immunotherapy developer Vaximm AG. The...

MORE

Swedish clinical-stage biopharmaceutical company Aprea AB has named Christian Schade President and Chief...

MORE

Brussels-based vaccine developer Univac has appointed a new CEO. In March, Stefano Malvolti joined Univac...

MORE

Faron Pharmaceuticals has someone new to oversee its drug development strategy. In early May, the Turku-based...

MORE

US- and UK-based genomics company Inivata has appointed Timothy Shannon as Chief Financial Officer. Shannon...

MORE